Clinical Trial Update: A Study in Schizophrenic Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial in schizophrenia was terminated; results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Snippet

Sponsor: Denovo Biopharma LLC | Conditions: Schizophrenia | Phase 2 | Status: TERMINATED | Results posted: 2021-09-14